- Creates late-stage, diversified pipeline that uses a multi-targeted approach to reset dysregulated biology to address considerable unmet needs
- Combined pipeline extends from pre-clinical to registration studies, with near-term clinical and regulatory milestones
- Acquired lead asset will begin a fully-funded registration trial anticipated to start by year-end
Author Archive: AZBio
Breakthrough study uses genetic testing to evaluate risk of heart disease
(PHOENIX, Ariz. – Feb. 17, 2022) –Dignity Health in Arizona is launching the first research study in North America in which genetic testing is used to identify men and women at risk of developing heart disease based on the makeup of their DNA. If proven effective in clinical trials, this form of genetic testing may be adopted globally to prevent heart disease. Heart disease is the No. 1 killer in the world – in fact, half of Americans are expected to have at least one cardiac event in their lifetime. Continue reading
What Drives the Creation and Delivery of Cures and What Doesn’t
AZBio President & CEO, Joan Koerber-Walker, shared insights with Duane Schulthess, Managing Director of Vital Transformation on the the Vital Health Podcast. The popular podcast series has a global reach and features relaxed, one on one discussion with health care professionals, researchers, and regulators. Topics explore the implications of new medical procedures, technologies and policies as well as their impact on current clinical practices.
Four UArizona Faculty Named to the National Academy of Inventors
New Senior Members’ inventions range from a beating heart patch to optical devices that have enabled the modern internetContinue reading
Local Bioscience Company Founder Aspires to Serve In Arizona Senate
Members of the Arizona bioscience and healthcare community work every day to discover, develop, and deliver life changing and live saving solutions. Now, one Arizona life science leader aspires to take what he has learned as a bioscience company co-founder and CEO and use it to build solutions as an Arizona State Senator. Meet David W. Richardson.
Arizona Commerce Authority Awards Round 1 FAST Grants
The grant enables startups to advance their application process for research & innovation resources. Round 1 FAST grants went to Consequent Labs, OXbyEL Technologies, TheraCea, Resuture, TapRoot Interventions & Solutions, and LEMNA!. Round 2 applications close on April 30, 2022.Continue reading
New Study to Explore Link Between Hypertension Treatment and Development of Heart Failure
Researchers will Study How Drug Used to Lower Blood Pressure can Change Fibroblasts to Provide Long-Lasting Protection for the HeartContinue reading
Arizona Companies On Deck to Speak at BIO CEO in NYC
OncoMyx Therapeutics and Avery Therapeutics will be presenting at BIO CEO.Continue reading
A Path for Hope: Startup pursues first regenerative treatment for Alzheimer’s disease
“Starting up NeuTherapeutics is so exciting because we are creating the path to bring the first regenerative therapeutic for Alzheimer’s disease to those who need it. We believe that treatment with allo will restore brain function and independence for patients,” says Dr. Roberta Brinton, a Regents Professor of pharmacology and neurology and a member of the BIO5 Institute.
Meet Zoey – AZBio’s Social Media and Communications Intern
Zoey Leipsic joined the AZBio Team in January of 2022 as our Social Media and Communications Intern. In her role, Zoey collects the latest news from our AZBio Member Companies and shares it via posts on AZBio.org as well as on AZBio’s social media accounts so that more people can learn about the important work you do.Continue reading